# Bacteriophage vB_SepP_134 and Endolysin LysSte_134_1 as Potential Staphylococcus-Biofilm-Removing Biological Agents

**Authors:** Natalia N. Golosova, Andrey L. Matveev, Nina V. Tikunova, Yana A. Khlusevich, Yulia N. Kozlova, Vera V. Morozova, Igor V. Babkin, Tatiana A. Ushakova, Elena V. Zhirakovskaya, Elizaveta A. Panina, Elena I. Ryabchikova, Artem Y. Tikunov

PMC · DOI: 10.3390/v16030385 · Viruses · 2024-02-29

## TL;DR

This paper introduces a new bacteriophage and its endolysin that can destroy Staphylococcus biofilms, offering potential new treatments for antibiotic-resistant infections.

## Contribution

A new bacteriophage vB_SepP_134 and its endolysin LysSte134_1 are identified as effective against Staphylococcus biofilms.

## Key findings

- The bacteriophage vB_SepP_134 infects multiple Staphylococcus species and clinical strains.
- Endolysin LysSte134_1 effectively breaks down biofilms formed by S. aureus and S. epidermidis.
- LysSte134_1 shows catalytic activity against peptidoglycans from various Staphylococcus species.

## Abstract

Bacteria of the genus Staphylococcus are significant challenge for medicine, as many species are resistant to multiple antibiotics and some are even to all of the antibiotics we use. One of the approaches to developing new therapeutics to treat staphylococcal infections is the use of bacteriophages specific to these bacteria or the lytic enzymes of such bacteriophages, which are capable of hydrolyzing the cell walls of these bacteria. In this study, a new bacteriophage vB_SepP_134 (St 134) specific to Staphylococcus epidermidis was described. This podophage, with a genome of 18,275 bp, belongs to the Andhravirus genus. St 134 was able to infect various strains of 12 of the 21 tested coagulase-negative Staphylococcus species and one clinical strain from the Staphylococcus aureus complex. The genes encoding endolysin (LysSte134_1) and tail tip lysin (LysSte134_2) were identified in the St 134 genome. Both enzymes were cloned and produced in Escherichia coli cells. The endolysin LysSte134_1 demonstrated catalytic activity against peptidoglycans isolated from S. aureus, S. epidermidis, Staphylococcus haemolyticus, and Staphylococcus warneri. LysSte134_1 was active against S. aureus and S. epidermidis planktonic cells and destroyed the biofilms formed by clinical strains of S. aureus and S. epidermidis.

## Linked entities

- **Species:** Staphylococcus epidermidis (taxon 1282), Staphylococcus aureus (taxon 1280), Staphylococcus haemolyticus (taxon 1283), Staphylococcus warneri (taxon 1292), Escherichia coli (taxon 562)

## Full-text entities

- **Genes:** coagulase [NCBI Gene 28379458]
- **Diseases:** staphylococcal infections (MESH:D013203)
- **Species:** Bacteriophage sp. (species) [taxon 38018], Escherichia coli (E. coli, species) [taxon 562], Staphylococcus aureus (species) [taxon 1280], Staphylococcus epidermidis (species) [taxon 1282], Staphylococcus haemolyticus (species) [taxon 1283], Staphylococcus warneri (species) [taxon 1292]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10975630/full.md

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10975630/full.md

## References

70 references — full list in the complete paper: https://tomesphere.com/paper/PMC10975630/full.md

---
Source: https://tomesphere.com/paper/PMC10975630